United Kingdom Insulin Delivery Devices Market Insight
The United Kingdom Insulin Delivery Devices Market is growing at an 9.14%CAGR, driven by rising diabetes prevalence, NHS adoption, and demand for smart insulin delivery technologies.
United Kingdom Insulin Delivery Devices Market Insights Forecasts to 2035
- The United KingdomInsulin Delivery Devices Market Size Was Estimated at USD 867.3Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 9.14% from 2025 to 2035
- The United Kingdom Insulin Delivery Devices Market Size is Expected to Reach USD 2080.6Million by 2035
Notable Insights for United Kingdom Insulin Delivery Devices Market
- By product type, insulin pens dominated, accounting for approximately 55–60% share in 2024, due to ease of use and improved patient adherence.
- By device type, smart insulin pumps held approximately 30–35% share, driven by integration with continuous glucose monitoring (CGM) systems.
- Around 70–75% of insulin-dependent patients in the UK prefer pen-based delivery systems over syringes due to convenience and reduced dosing errors.
- Nearly 25–30% of Type 1 diabetes patientsin the UK are adopting automated insulin delivery or hybrid closed-loop systems.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Insulin Delivery Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Insulin Delivery Devices Market
- Medtronic
- Insulet Corporation
- Tandem Diabetes Care
- Novo Nordisk
- Eli Lilly and Company
- Ypsomed
- Roche
- Sanofi
- Others
Recent Developments:
- In August 2025, Trividia Health introduced 5-bevel insulin pen needles in 31G and 32G sizes, enhancing injection comfort and reducing pain for diabetes patients in the UK market.
- In July 2025, 33G x 4mm ultra-thin insulin pen needles featuring 5-bevel sharp tip technology are now available on prescription in the UK, improving injection comfort for diabetes patients.
Market Segmentation:
United Kingdom Insulin Delivery Devices Market, By Product Type
- Insulin Pens
- Insulin Pumps
- Syringes
- Smart Insulin Delivery Systems
- Others
United Kingdom Insulin Delivery Devices Market, By Technology
- Manual Devices
- Connected Devices
- Automated Insulin Delivery Systems
United Kingdom Insulin Delivery Devices Market, By End User
- Hospitals & Clinics
- Home Care Settings
- Diabetes Care Centers
United Kingdom Insulin Delivery Devices Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Channels
Expert Views:
The UK Insulin Delivery Devices Market is expected to grow steadily due to increasing diabetes prevalence and strong NHS focus on digital and automated insulin management. Experts highlight insulin pens as the dominant segment, while smart pumps and closed-loop systems are rapidly expanding. Integration of IoT-enabled devices and continuous glucose monitoring is expected to transform diabetes care and improve long-term patient outcomes through 2035.